The monoclonal antibody reduced the incidence of RSV-associated medically attended lower respiratory infections that had at least one indicator of lower respiratory infection or severity by 60.5% ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.

A third monoclonal antibody product to protect babies against respiratory syncytial virus was approved by the Food and Drug Administration on Monday, a development public health experts hope may ...

Antibodies are indispensable in biomedicine. However, conventional antibody development faces challenges, including high costs and lengthy production timelines spanning months. Here, we present a data ...

Migratory birds develop antibodies to bird flu, officials say by: Karina F. Garcia Posted: Jun 6, 2025 / 06:33 PM EDT Updated: Jun 6, 2025 / 06:34 PM EDT ...